Click here to sort or use the bar above to filter results
Chapter 1 - Gastro-intestinal System
1.1 Dyspepsia & gastro-oesophageal reflux disease
1.2 Antispasmodics
1.3 Antisecretory drugs
1.3.5 Proton pump inhibitors (PPI)
1.3.5 Helicobacter pylori eradication
1.4 Acute diarrhoea
1.5 Chronic bowel disorders
Guidance on assessing dehydration in children under 5 years
1.6 Laxatives
1.7 Local preparations for anal and rectal disorders
Chapter 2 - Cardiovascular System
2.1 Positive inotropic drugs
2.2 Diuretics
2.3 Anti-arrhythmic drugs
2.4 Beta-adrenoreceptor blocking drugs
2.5 Drugs affecting the renin-angiotensin system
2.5 Summary of Antihypertensive Drug Treatment
2.5 Care Pathway for Hypertension
2.5 Prescribing Guidelines for Heart Failure Guidance
2.6 Nitrates, CCBs and potassium channel activators
2.6 Primary Care Guidelines for drug treatment of Chronic Stable Angina Pectoris
2.6.3 Other antianginal drugs
2.6.4 Peripheral vasodilators and related drugs
2.8 Anticoagulant drugs
2.8.2 Oral anticoagulants
2.8.2 Drug Interactions for Apixaban, Dabigatran, Edoxaban and Rivaroxaban
2.8.2 Decision aid for patients requiring stroke prevention in AF
2.8.2 Reducing the risk of stroke in Atrial Fibrillation - NICE CG180 (including decision aid)
2.8.2 NOAC Implementation priorities
2.9 Antiplatelet drugs
2.12 Lipid regulation
2.12 Lipid regulating drugs
Chapter 3 - Respiratory System
3 Introduction
Asthma Inhaler Pathways
Asthma Step-down Guides
Summary of recently introduced inhalers and their equivalents
3.1 Bronchodilators
3.2 Corticosteroids
3.3.2 Leukotriene receptor antagonists
Guidance for managing COPD
3.4.1 - Antihistamines
3.7 - Mucolytics
Chapter 4 - Central Nervous System
4.1 - Hypnotics and anxiolytics
4.2 - Drugs used in psychoses and related disorders
4.2.3 - Antimanic drugs
4.3 - Antidepressants
4.5 - CNS stimulants and drugs for ADHD
4.5.1 - Drugs used in the treatment of obesity
4.7 - Analgesics
4.7.3 - Neuropathic pain
4.7.4 - Antimigraine drugs
4.8.1 - Epilepsy
4.8.2 - Drugs used in status epilepticus
4.10 - Drugs used in substance dependence
4.11 - Drugs for dementia
Chapter 5 - Infections
link to Management of Infection Guidance for Primary Care
5.1 - Antibacterial drugs
5.2 - Antifungal drugs
5.3 - Antiviral drugs
Chapter 6 - Endocrine System
6.1 - Drugs used in diabetes
6.1.1 - Insulins
6.1.2 - Drugs used in diabetes
6.1 - Guidance on the use of Blood Glucose Testing Strips
6.2 - Thyroid and anti-thyroid drugs
6.3 - Corticosteriods
6.4.1 - Hormone Replacement Therapy
6.4.2 - Male sex hormones and antagonists
6.5.2 - Posterior pituitary hormones and antagonists
6.6 - Drugs affecting bone metabolism
6.6 - Protocol for primary care management of patients prescribed PROLIA® (Denosumab) for prevention of fractures
Chapter 7 - Obstetrics, Gynaecology and Urinary Tract Disorders
7.2 - Treatment of vaginal and vulval conditions
7.3 - Contraceptives
7.3 - Consillient Pill Equivalences and VTE Risk
7.4.1 - Drugs for urinary retention
7.4.2 - Drugs for urinary frequency, enuresis and incontinence
7.4.5 - Drugs for erectile dysfunction
7.4.6 - Drugs for premature ejaculation
Chapter 8 - Malignant Disease and Immunosuppression
8.3 - Sex Hormones and Hormone Antagonists in Malignant Disease
Chapter 9 - Nutrition and Blood
9.1 - Anaemias and some other blood disorders
9.2 - Fluids and electrolytes
9.5 - Minerals
9.6 - Vitamins
Chapter 10 - Musculoskeletal and joint diseases
10.1 – Drugs used in Rheumatic Disease and Gout
10.1 – Treatment of Gout
10.1- Management of Osteoarthritis
Chapter 11 – Eye
11.3 – Anti-infective eye preparations
11.4 – Corticosteriods and other anti-inflammatory preparations
11.5 – Mydriatics and Cycloplegics
11.6 – Treatment of Glaucoma
11.8 – Miscellaneous ophthalmic preparations
Chapter 12 – Drugs acting on the Ear
12.1 – Drugs acting on the Nose
12.2 – Nasal Allergy
12.3 – Drugs acting on the Oropharynx
Chapter 13 – Skin
13.2 – Emollient and barrier preparations guidance
13.2.1 – Emollients
3.2.1.1 – Emollient bath additives and shower preparations
13.3 – Local Anaesthetics and Antipruritics
13.4 – Topical corticosteriods
13.5 – Preparations for Eczema and Psoriasis
13.6.1 – Topical preparations for acne
13.6.2 – Oral preparations for acne
13.8 – Photodamage
13.10 –Anti-infective skin preparations
Chapter 15 – Anaesthesia
15.1.7 – Antagonists for central and respiratory depression